Condition: Heart Failure · CAD - Coronary Artery Disease · CABG · Sponsor: Tomsk National Research Medical Center of the Russian Academy of Sciences
PROFILE-HF is a multicenter, observational, prospective study of the clinical course and outcomes of chronic heart failure (HF) and coronary artery disease (CAD) in patients undergoing coronary artery bypass grafting (CABG). The objective of the study is to develop a method for assessing the risk of adverse cardiovascular events in patients with CAD and HF who have undergone CABG, based on preoperative GDF-15 concentrations. The study will have a 12-month follow-up period; one in-person visit is planned at the end of the follow-up period. If it is not possible to visit a doctor in person, information will be collected through telephone contact with the patient or his relative or person caring for the patient.
This description comes directly from the study's public registry record.
Alla A. Garganeeva, MD, PhD · +7 (3822) 56 52 75 · aag@cardio-tomsk.ru
Elena A. Kuzheleva, MD, PhD · +7 (3822) 56 52 75 · kea@cardio-tomsk.ru
Always discuss trial participation with your own doctor first.
| Cardiology Research Institute, Tomsk National Research Medical Center Russian Academy of Sciences | Tomsk, Tomsk Oblast, Russia | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07480915